Citigroup Inc. Lowers Position in Mastercard Incorporated $MA
Citigroup Inc. reduced its stake in Mastercard Incorporated by 7.7% in Q3 2025, selling 70,851 shares and now owning 848,371 shares valued at approximately $482.6 million. Despite this, Mastercard's stock opened at $525.94, reported strong Q4 earnings beating estimates with $4.76 EPS and $8.81 billion in revenue, and has a consensus "Buy" rating from analysts with an average price target of $669.27, supported by strategic partnerships and product innovations.
Citigroup Inc. Purchases 33,516 Shares of Spotify Technology $SPOT
Citigroup Inc. increased its stake in Spotify Technology by 11.3% in the third quarter, acquiring an additional 33,516 shares, bringing their total to 330,402 shares valued at approximately $230.6 million. Spotify recently exceeded earnings expectations with $5.16 EPS against an anticipated $3.16 and revenue of $5.32 billion, surpassing the $5.14 billion estimate. Analysts currently maintain a "Moderate Buy" rating for Spotify, with an average price target of $706.42.
ING Group, N.V. (NYSE:ING) Given Average Recommendation of "Buy" by Brokerages
ING Group, N.V. (NYSE:ING) has received a consensus "Buy" recommendation from nine research firms. The company reported mixed quarterly results with EPS beating estimates but revenue missing. ING Group also announced a dividend of $0.8796 payable on May 1st.
Advyzon Investment Management LLC Boosts Holdings in ProShares UltraPro QQQ $TQQQ
Advyzon Investment Management LLC significantly increased its stake in ProShares UltraPro QQQ (TQQQ) by 145.6% in Q3, holding 45,678 shares valued at $4.723 million. This surge reflects a broader institutional accumulation, with other major firms like Howard Capital, Citigroup, and Goldman Sachs also substantially boosting their TQQQ holdings. Additionally, ProShares UltraPro QQQ recently increased its quarterly dividend to $0.0855 per share, up from $0.05.
Kodiak Gas Services (NYSE:KGS) Upgraded by Wall Street Zen to "Hold" Rating
Wall Street Zen has upgraded Kodiak Gas Services (NYSE:KGS) from a "sell" to a "hold" rating, though the broader analyst consensus remains a "Moderate Buy" with a $47.00 target price. The company's shares are trading strongly near their 1-year high, reflecting a $4.38 billion market cap and increased institutional investment. Several other analysts have recently updated their ratings and price targets for Kodiak Gas Services, predominantly giving "Buy" or "Outperform" ratings.
Citigroup Maintains 'Buy' Rating on EVRG, Increases Price Target to USD 95 | EVRG Stock News
Citigroup has reiterated its 'Buy' rating on Evergy (EVRG) and raised its price target from USD 89 to USD 95, representing a 6.74% increase. This update comes amidst several other recent analyst adjustments for Evergy, including UBS downgrading to 'Neutral' and BMO Capital maintaining 'Outperform'. Evergy, a regulated electric utility, has an average analyst price target of $85.36, suggesting a 6.35% upside from its current price, although GuruFocus estimates a downside based on its GF Value.
ProShares' stablecoin-ready ETF generates record $17 billion in day-one trading volume
The ProShares GENIUS Money Market ETF (IQMM) has set a new record for first-day trading volume, generating $17 billion. The ETF is designed to hold assets meeting legal reserve requirements for dollar-backed stablecoins in the U.S., aligning with the GENIUS Act. This significantly surpasses previous ETF launch volumes, including BlackRock's spot bitcoin ETF.
Brianne Gardner's Top Picks: ATS Corp, NRG Energy & Netflix
Brianne Gardner, a senior wealth manager at Velocity Investment Partners, Raymond James, has revealed his top stock picks. The article highlights his selections: ATS Corp, NRG Energy, and Netflix, offering insights for investors.
Citi Boosts Progress Software Price Target Amid AI Prospects
Citi analyst Fatima Boolani has raised the price target for Progress Software to $60, citing strong earnings and cash flow, alongside the company's strategic focus on AI-driven initiatives. Progress Software's shares surged over 8% in premarket trading following its fiscal Q4 report, which surpassed market expectations for both earnings and revenue. Despite a slight trim in Wedbush's price prediction, the firm maintains an "Outperform" rating, reflecting continued optimism for Progress Software's growth trajectory into 2026.
Microsoft Valuation Hits Decade-Low: Citigroup Issues Rare "Buy" Alert Amid AI Volatility
Citigroup analysts have issued a "Buy" rating for Microsoft (MSFT), citing its valuation hitting a decade-low despite a broader tech sector sell-off. The report highlights a "rare valuation gap" due to the market punishing Microsoft's high CapEx in AI infrastructure, even as its Azure cloud service shows strong growth. Citigroup believes this creates a prime opportunity for investors, predicting significant upside as new data center capacity comes online and Copilot drives software revenue.
C's January Card Delinquencies Rise: How it Will Impact Asset Quality?
Citigroup Inc.'s Citibank N.A. reported a mixed credit card performance for January 2026, with an increase in delinquency rates but a decrease in net charge-off rates compared to the prior month. While the decline in charge-offs is positive, the rise in delinquencies and reduced principal receivables indicate ongoing consumer pressure, potentially impacting the company's asset quality. Despite these challenges, Citigroup's stock has performed well over the past six months and is trading at an attractive valuation.
Coherent Corp. Surges on Upbeat Q2 Earnings and Raised Price Targets
Coherent Corp. (NYSE: COHR) saw its stock surge by 7.41% following strong Q2 earnings, with revenue of $1.69B and EPS of $1.29, both exceeding estimates. The growth, primarily driven by demand in the datacenter and communications sectors, has led investment banks like Citi and JPMorgan to raise their price targets and ratings. The company's focus on AI accelerators and strategic capacity expansion in indium phosphide, along with industry accolades, indicates promising future performance and sustained investor confidence.
Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up - Here's What Happened
Telix Pharmaceuticals (NASDAQ:TLX) experienced a gap-up in its share price before trading on Friday, opening at $7.46 after closing at $6.71, and last trading at $7.8170. The stock has an average "Moderate Buy" rating from analysts with an average target price of $21.00. Institutional investors have also shown increased interest, with several funds either increasing or initiating positions in the company during recent quarters.
Orient Plus International Ltd. et al v. Baosheng Media Group Holdings Ltd. et al: Complaint (‘Material Misstatements or Omissions’)
This article provides details of a complaint filed in the U.S. District Court for the Southern District of New York by Orient Plus International Limited and others against Baosheng Media Group Holdings Limited and several individuals and entities. The complaint alleges "Material Misstatements or Omissions" and involves a publicly-listed Cayman Islands firm providing online marketing solutions in China. The complete content is behind a subscription wall.
APi Group Corporation $APG Stock Holdings Increased by State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D significantly increased its holdings in APi Group Corporation ($APG) by 58% during the third quarter, acquiring an additional 39,930 shares. Other institutional investors also adjusted their positions, with notable increases from Cullen Frost Bankers Inc. and Whittier Trust Co. Insider activity shows Director Anthony E. Malkin purchased 3,000 shares, boosting his direct ownership by 75%.
Karman Holdings stock slips as Citi-fueled rally cools; what’s next for KRMN shares
Karman Holdings (KRMN) stock experienced a drop of roughly 4% after a significant rally fueled by a positive Citigroup report. Citi had maintained its "Buy" rating and a $125 price target, placing the stock on an "upside 90-day catalyst watch," which led to gains of nearly 18% over two sessions. The recent slip is seen as profit-taking, but ongoing risks include contract timing, government budgets, and the challenges of integrating new acquisitions.
Candel Therapeutics stock falls on $100 million offering pricing
Candel Therapeutics (NASDAQ:CADL) shares dropped significantly after the company priced a public offering of over 18 million shares at $5.45 each, aiming to raise $100 million. The biopharmaceutical company plans to use the proceeds for commercial activities of its cancer immunotherapy aglatimagene besadenovec and to fund ongoing development costs for its Phase 3 trial.
Vanguard Group Inc. Acquires 552,360 Shares of Best Buy Co., Inc. $BBY
Vanguard Group Inc. increased its stake in Best Buy Co., Inc. (NYSE:BBY) by 2.4% in the third quarter, acquiring an additional 552,360 shares and bringing its total ownership to 23,947,415 shares, valued at approximately $1.81 billion. This makes Vanguard Group Inc. the largest institutional holder with 11.40% of the company. Best Buy recently beat quarterly earnings estimates and offers a 5.8% dividend yield, despite a "Hold" consensus rating from analysts and a trading price of $65.85 against an average target of $80.32.
Vanguard Group Inc. Decreases Stake in C.H. Robinson Worldwide, Inc. $CHRW
Vanguard Group Inc. reduced its stake in C.H. Robinson Worldwide, Inc. by 3.0% in the third quarter of 2025, selling 441,684 shares. Despite this, insiders like CEO David P. Bozeman have made recent stock purchases. C.H. Robinson reported EPS of $1.23, exceeding estimates, with a "Moderate Buy" consensus rating from analysts and an average price target of $181.29.
Vanguard Group Inc. Sells 635,914 Shares of US Foods Holding Corp. $USFD
Vanguard Group Inc. reduced its stake in US Foods Holding Corp. by 2.8%, selling over 635,000 shares but still maintaining a significant holding. The company reported strong EPS that beat expectations but slightly missed on revenue, offering positive FY2026 guidance. Analysts generally rate US Foods as a "Moderate Buy" with an average target price above its current trading value.
Enova International, Inc. SEC 10-K Report
Enova International, Inc. has released its 2025 10-K report, detailing substantial growth in revenue and net income, driven by expanded consumer and small business portfolios. The report highlights strategic initiatives such as the acquisition of Grasshopper to enhance digital banking capabilities and increased borrowing capacity to fund future growth. However, the company also acknowledges significant regulatory, operational, and market risks in its highly regulated industry.
Vanguard Group Inc. Sells 19,843 Shares of Ciena Corporation $CIEN
Vanguard Group Inc. reduced its stake in Ciena Corporation (NYSE:CIEN) by 0.1%, selling 19,843 shares, but still holds over 15 million shares valued at approximately $2.20 billion. The article highlights significant insider selling, with CEO Gary B. Smith and Director Patrick Gallagher offloading shares totaling millions. Despite insider sales, analysts have become more bullish on Ciena, with a consensus "Moderate Buy" rating and increased price targets, as the company beat EPS estimates and showed strong revenue growth.
Jupiter Asset Management Ltd. Has $186.33 Million Stock Holdings in Citigroup Inc. $C
Jupiter Asset Management Ltd. significantly increased its stake in Citigroup Inc. by 440.5% in the third quarter, bringing their total holdings to 1,835,767 shares valued at $186.33 million. Other institutional investors have also adjusted their positions in Citigroup, which has seen varied analyst ratings, culminating in a "Moderate Buy" consensus and a $127.25 target price. Recent insider trading shows a significant sale by Cantu Ernesto Torres, while strategic moves by Citigroup include exiting its Russian unit and focusing on higher returns.
Persistent Asset Partners Ltd Decreases Position in Bank of America Corporation $BAC
Persistent Asset Partners Ltd significantly reduced its stake in Bank of America Corporation (NYSE:BAC) by 51.6% during the third quarter, selling 9,687 shares and now owning 9,091 shares valued at $469,000. Despite this reduction, several other institutional investors increased their holdings, while Bank of America announced a quarterly dividend of $0.28 per share and analysts adjusted price targets, leading to an average "Moderate Buy" rating for the stock. The article also highlights recent positive and negative news impacting BAC, including a new rewards program, potential regulatory easing, and concerns about private-credit commitments and Warren Buffett's trimmed position.
Citigroup looks at the scenarios for crude as tensions rise
Citigroup has analyzed various scenarios for crude oil prices amidst rising U.S.-Iran tensions, which are causing oil prices to see their first weekly gain in three weeks. The bank presents a bull case of $70-75/bbl for Brent if supply risks persist without a Strait of Hormuz blockage, a base case averaging $67/bbl in Q1'26 dropping to $62/bbl later in 2026, and a bear case of $50/bbl due to weak demand and increased OPEC+ output. The report highlights that an escalation leading to transit disruptions in the Strait of Hormuz could cause further price increases.
Fiverr International (NYSE:FVRR) Rating Lowered to "Hold" at Citigroup
Citigroup has downgraded Fiverr International (NYSE:FVRR) from "strong-buy" to "hold," causing the stock to plunge 8.5% to near 52-week lows, with a current market cap of $405 million. This downgrade, alongside target price cuts from several other firms, reflects concerns over the company's FY26 outlook and potential AI headwinds, despite beating Q4 EPS estimates. The consensus rating for Fiverr is now "Hold" with an average price target of $19.30.
Barclays (NYSE:BCS) Raised to Strong-Buy at Zacks Research
Zacks Research has upgraded Barclays (NYSE:BCS) to a "strong-buy" rating, reflecting a positive outlook from analysts. The financial services provider recently reported strong earnings, beating consensus estimates with $0.46 EPS. Despite a slight dip in share price, the company maintains a stable financial profile, and institutional investors have shown modest increases in their stakes.
LPL Financial Holdings Inc. $LPLA Shares Sold by NewEdge Wealth LLC
NewEdge Wealth LLC reduced its stake in LPL Financial (NASDAQ: LPLA) by 41.3% in Q3, selling 15,079 shares and retaining 21,394 shares valued at $7.12 million. LPL Financial exceeded Q4 expectations with an EPS of $5.23 and revenue of $4.93 billion, maintaining a "Moderate Buy" consensus rating and a target price of $428.71. Despite insider sales totaling $2.18 million, institutional investors hold about 95.7% of the stock, and the company declared a quarterly dividend of $0.30.
Emerson Electric Company (EMR) Receives a Buy from Citi
Citi analyst Andrew Kaplowitz has maintained a Buy rating on Emerson Electric Company (EMR) with a price target of $174.00 following the company's recent earnings report. Emerson reported quarterly revenue of $4.35 billion and a net profit of $605 million, while overall analyst consensus remains a Moderate Buy despite some negative corporate insider sentiment.
Prudential (LON:PRU) Stock Price Passes Above 200-Day Moving Average - Time to Sell?
Prudential plc's (LON:PRU) shares recently surpassed their 200-day moving average, trading as high as GBX 1,128.50 on Thursday, with a current stock price of GBX 1,112. The company has received positive analyst ratings from Citigroup and JPMorgan Chase & Co., both recommending a "Buy" or "Overweight" rating with target prices significantly above the current trading price. Despite this, MarketBeat's top analysts suggest other stocks might be better buys than Prudential for immediate investment.
Lamar Advertising Company Reports Strong Q4 and Full-Year 2025 Financial Results with Increased Revenues and Net Income
Lamar Advertising Company announced strong financial results for Q4 and full-year 2025, with net revenues rising 2.8% to $595.9 million in Q4 and net income reaching $154.7 million, a significant improvement from a net loss in the previous year. For the full year, net income increased by 63.4% to $593.1 million, partly due to a gain from the sale of its Vistar Media stake. The company projects diluted AFFO per share for fiscal year 2026 to be between $8.50 and $8.70, indicating a positive outlook.
Factory Mutual Insurance Co. Buys New Stake in British American Tobacco p.l.c. $BTI
Factory Mutual Insurance Co. recently acquired a new stake of 64,145 shares, valued at approximately $3.4 million, in British American Tobacco (NYSE: BTI) during the third quarter. This move aligns with increased institutional investor interest, as several firms significantly boosted their positions in BTI. Analysts maintain a "Moderate Buy" consensus rating for the stock, with a target price of $51.00, and the company has declared a quarterly dividend of $0.8349, yielding 5.5%.
39,650 Shares in UnitedHealth Group Incorporated $UNH Purchased by Compass Wealth Management LLC
Compass Wealth Management LLC recently acquired 39,650 shares of UnitedHealth Group (NYSE:UNH) valued at approximately $13.69 million, making it their 14th largest holding. Other institutional investors like Geode Capital Management and Norges Bank have also significantly increased their positions in the healthcare conglomerate. UnitedHealth Group reported strong Q3 earnings, surpassing analyst estimates, and analysts currently hold a "Moderate Buy" consensus rating for the company with an average target price of $372.13.
What Price Targets Have Wall Street Analysts Set for O'Reilly Automotive Shares?
O'Reilly Automotive (ORLY) has shown resilience with its stock performance, despite slightly underperforming the S&P 500 over the past year. The company reported strong Q4 2025 results, with revenue growth and comparable store sales at the high end of guidance, and projects optimistic growth for fiscal 2026. Wall Street analysts maintain a positive outlook on ORLY, with a consensus "Strong Buy" rating and a price target suggesting a 14.7% potential upside.
Candel Therapeutics prices $100M public offering
Candel Therapeutics (NASDAQ:CADL) has priced a public offering of approximately 18.3 million shares at $5.45 each, aiming to raise $100 million in gross proceeds. The funds will support commercialization activities for aglatimagene besadenovec (CAN-2409) in prostate cancer and ongoing development for its Phase 3 trial in non-small cell lung cancer. Citigroup, Cantor, and Stifel are joint bookrunning managers for the offering.
Citi Lowers PT on Hewlett Packard Enterprise Company (HPE)
Citi analyst Asiya Merchant lowered the price target for Hewlett Packard Enterprise (HPE) from $28 to $26, while maintaining a Buy rating. This adjustment reflects the firm's broader review of the hardware and storage sector due to mixed end-market demand and ongoing uncertainty in customer spending. Despite this, Goldman Sachs previously upgraded HPE to Buy, citing the transformative acquisition of Juniper Networks, which is expected to shift HPE's revenue mix towards higher-margin networking services.
Citigroup Maintains Buy on KRMN Karman Holdings Inc Feb 19 2026
Citigroup maintained a "Buy" rating on Karman Holdings Inc (KRMN) on February 19, 2026, and initiated an "upside 90-day catalyst watch" following management meetings, without issuing a new price target. This action signals continued confidence in KRMN and highlights potential near-term operational events, driving a 3.33% stock increase. Given limited analyst coverage for Karman, this high-profile note from Citi is significant, and Meyka AI rates KRMN with a B+ grade based on various financial and market factors.
Telephone and Data Systems Gears Up For Q4 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Telephone and Data Systems (NYSE: TDS) is set to release its Q4 earnings on Friday, February 20, before the market opens. Analysts anticipate earnings of 8 cents per share and quarterly revenue of $322.04 million. Several accurate analysts have recently updated their ratings and price targets for the company ahead of the earnings call.
What Are Wall Street Analysts' Target Price for O'Reilly Automotive Stock?
O'Reilly Automotive, Inc. (ORLY) has shown relative stability and growth, with shares rising nearly 9% over the past 52 weeks and 3.3% year-to-date, outperforming its sector and the broader S&P 500 in some periods. Despite missing Q4 EPS estimates slightly, the company reported strong revenue growth and comparable store sales, and analysts maintain a "Strong Buy" rating with significant upside potential. The average price target for ORLY stock is $108.04, representing a potential upside of 14.7%.
i-80 Gold Corp. (IAU) Releases Q4 2025 Earnings: Revenue Down, Gross Profit Up, Large Net Loss
i-80 Gold Corp. (IAU) reported Q4 2025 earnings with an 8.35% decrease in revenue to $21.3 million, but a significant 173.68% increase in gross profit to $4.9 million. The company recorded a large net loss of -$71.9 million, up 840.83% year-over-year, alongside improved cash used in operating activities and strengthened cash reserves of $102.9 million. Institutional investors showed mixed activity, with some significantly adding to and others reducing their IAU positions in Q4 2025.
Alphabet’s Walker sells $14.3 million in GOOGL stock
John Kent Walker, President of Global Affairs and CLO at Alphabet Inc. (NASDAQ:GOOGL), sold 46,975 Class C Capital Stock shares for approximately $14.3 million on February 17, 2026. This transaction occurred at weighted average prices between $297.7 and $304.47, with the shares currently valued at $302.85, representing a strong 65% gain over the past year. Despite the stock appearing overvalued relative to its Fair Value by InvestingPro analysis, Alphabet maintains a low P/E ratio of 28 given its near-term earnings growth potential.
Citigroup Names New West Coast Leader for Private Banking Division
Citigroup has appointed Chad Reddy as the new market executive for its western private banking operations, underscoring its commitment to expanding its North American private banking presence. Reddy, a veteran in wealth management with 25 years of experience from Bank of America and Wells Fargo, will report to Chris Biotti, head of Citi Private Bank North America. This strategic hire aims to strengthen Citigroup's offerings in the region.
Candel Therapeutics Announces Proposed $100 Million Public Offering
Candel Therapeutics, a clinical-stage biopharmaceutical company, announced a proposed underwritten public offering of $100 million of its common stock, with an option for underwriters to purchase an additional $15 million. The company plans to use the net proceeds to fund launch readiness, ongoing development costs for its lead product candidate aglatimagene besadenovec (CAN-2409) in prostate and non-small cell lung cancer, and for general corporate purposes. Citigroup, Cantor, and Stifel are acting as joint bookrunning managers for the offering.
Marsh & McLennan Issues $600 Million Senior Notes
Marsh & McLennan Companies has issued $600 million of 4.950% senior notes due in 2036. The issuance, underwritten by a syndicate including Citigroup Global Markets and J.P. Morgan Securities, strengthens the firm's long-term funding. TipRanks' AI Analyst, Spark, rates MRSH as Neutral, citing solid operating performance balanced by balance-sheet leverage risk and bearish technicals.
Carter's (CRI) Target Price Raised by UBS to $40 Despite Neutral Rating | CRI Stock News
UBS has maintained its Neutral rating for Carter's (CRI) but increased its target price to $40, a 21.21% rise from the previous target. This adjustment comes amidst various analyst updates, with some firms like Citigroup upgrading CRI to Buy with a $50 target, while others like Goldman Sachs and Barclays maintain Sell or Underweight ratings, yet still raising their price targets. Despite the varied analyst sentiments, the average target price from 5 analysts is $33.40, suggesting a potential downside, whereas GuruFocus estimates a GF Value of $66.90 based on fair value calculations.
Candel Therapeutics Announces Pricing of Public Offering
Candel Therapeutics announced the pricing of an underwritten public offering of 18,348,624 shares of its common stock at $5.45 per share, expecting to raise $100 million before deductions. The company plans to use the net proceeds for launch readiness, pre-commercialization, and commercial activities for aglatimagene besadenovec (CAN-2409) in prostate cancer, ongoing development for its use in non-small cell lung cancer, and general corporate purposes. Citigroup, Cantor, and Stifel are acting as joint bookrunning managers for the offering.
Candel Therapeutics Announces Proposed $100 Million Public Offering
Candel Therapeutics, a clinical-stage biopharmaceutical company, has announced a proposed underwritten public offering of $100 million in common stock, with an option for underwriters to purchase an additional $15 million. The net proceeds are intended for critical launch readiness and commercial activities for its lead product candidate, aglatimagene besadenovec (CAN-2409), in early, localized prostate cancer, ongoing development costs for its phase 3 trial in non-small cell lung cancer, and general corporate purposes. Citigroup, Cantor, and Stifel are acting as joint bookrunning managers for the offering.
Howard Hughes Holdings (NYSE: HHH) posts 2025 results and $2.1B Vantage acquisition plan
Howard Hughes Holdings Inc. reported its full-year 2025 financial results, with net income from continuing operations at $123.8 million, or $2.21 per diluted share, and Adjusted Operating Cash Flow of $446 million. The company announced its plan to acquire Vantage Group Holdings for approximately $2.1 billion, signaling a strategic shift to become a diversified holding company. Despite a decline in net income from the previous year, core real estate drivers, including Master Planned Communities and Total Operating Assets NOI, showed strong performance.
Citigroup Cuts Empire State Realty Trust (NYSE:ESRT) Price Target to $7.00
Citigroup has lowered its price target for Empire State Realty Trust (NYSE:ESRT) from $8.00 to $7.00, while maintaining a "neutral" rating. This adjustment reflects a cautious analyst sentiment, with other firms like Wells Fargo also reducing their targets and the stock trading near a 12-month low of $6.02. Despite these cuts, the consensus rating from MarketBeat for ESRT remains "Hold" with an average target price of $7.70.
Herc (NYSE:HRI) Given New $185.00 Price Target at Citigroup
Citigroup has lowered its price target for Herc (NYSE:HRI) to $185.00 from $195.00 but maintained a "buy" rating, indicating a potential upside of 28.31% from its current price. Other analysts have also adjusted their targets and ratings, contributing to a "Moderate Buy" consensus with an average price target of $178.29. The transportation company recently reported stronger-than-expected EPS but missed revenue forecasts, and its shares experienced a slight dip following the announcement.
